Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1997-1-2
|
pubmed:abstractText |
The non-classical HLA-G gene is the only class I antigen expressed in trophoblasts at the maternofetal interface. In placenta, the HLA-G gene produces several alternatively spliced isoforms encoding bound-membrane proteins (G1, G2, G3 and G4) lacking, respectively, exon 7; exons 7 and 3; exons 7, 3 and 4, and exons 7 and 4. In addition, two isoforms (G1s and G2s) containing an intron 4 sequence are able to encode soluble antigens. We have recently reported that the HLA-G gene is transcriptionally active in lymphocytes and is not transcribed in CD34+ cells, polynuclear cells or monocytes. To investigate the functional significance of the different isoforms in lymphocytes, we studied their distribution in normal T and B lymphocytes and in malignant lymphoid cells by using the RT-PCR technique followed by hybridization with exon-specific probes and sequencing assays. In transcriptionally active lymphocytes, the HLA-G primary transcript is the major form and is differentially spliced in B and T lymphocytes: (i) G1s is found in several samples of T and B cells whereas G2s is only transcribed in T lymphocytes, (ii) the G4 isoform is never detected in B lymphocytes. In addition, we have shown that HLA-G is inactive in some samples of lymphocytes. Our data suggest that HLA-G transcription is regulated at the initiation level and at the subsequent splicing. These two levels of regulation may be dysregulated in some cases of T-ALL and CLL. The potential functions of the HLA-G alternative forms in lymphocytes, such as peptide binding and modulation of the immune response, are discussed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0960-7420
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
311-20
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8858287-Alternative Splicing,
pubmed-meshheading:8858287-B-Lymphocytes,
pubmed-meshheading:8858287-HLA Antigens,
pubmed-meshheading:8858287-HLA-G Antigens,
pubmed-meshheading:8858287-Histocompatibility Antigens Class I,
pubmed-meshheading:8858287-Humans,
pubmed-meshheading:8858287-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:8858287-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:8858287-RNA, Messenger,
pubmed-meshheading:8858287-T-Lymphocytes
|
pubmed:year |
1996
|
pubmed:articleTitle |
Distribution of HLA-G alternative mRNAs including soluble forms in normal lymphocytes and in lymphoid cell-derived leukemia.
|
pubmed:affiliation |
University Laboratory for Hematology and Biology of Blood Cells, University of Rennes I, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|